Camtek
CAMT · NASDAQ
About CAMT
- Employees
- 709
- Headquarters
- Migdal HaEmek, Northern (HaZafon)
- Listed
- Jul 28, 2000
- Sector
- Information Technology
- Industry
- Semiconductors & Semiconductor Equipment
- Website
- camtek.com
CAMT key statistics
- Market cap
- 6.02B
- Price-earnings ratio
- 198.37
- Dividend yield
- —
- Average volume
- 530.57K
- Volume
- 416.74K
- Open price
- $127.62
- High today
- $130.73
- Low today
- $124.84
- 52 Week high
- $215.99
- 52 Week low
- $91.91
Camtek (CAMT) at a glance
Camtek (CAMT) last traded at $127.90, with a market cap of 6.02B and a price-to-earnings ratio of 198.37.
Today the stock has traded between $124.84 and $130.73. The current price is 2.5% above the day's low and 2.2% below its high.
Volume so far is 416.74K shares, below the average of 530.57K shares a day.
Over the past year Camtek has ranged from $91.91 to $215.99, and now sits 29% of the way up that range.
Camtek met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.78 per share against an estimate of $0.7746.
The average analyst price target is $188.97, 47.8% above the current price, from 10 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy70.0%
- Hold30.0%
- Sell0.0%
- Low
- $153.52
- Now
- $127.90
- High
- $210.00
CAMT earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 1.5% on average.
- Q3 FY24: reported $0.75 per share against an estimate of $0.7071
- Q4 FY24: reported $0.77 per share against an estimate of $0.7616
- Q1 FY25: reported $0.79 per share against an estimate of $0.786
- Q2 FY25: reported $0.79 per share against an estimate of $0.8081
- Q3 FY25: reported $0.82 per share against an estimate of $0.8191
- Q4 FY25: reported $0.81 per share against an estimate of $0.8296
- Q1 FY26: reported $0.70 per share against an estimate of $0.6967
- Q2 FY26: reported $0.78 per share against an estimate of $0.7746
CAMT news
- Press releasePRNewswire
- Press releasePRNewswire
CAMTEK TO HOST INVESTOR & ANALYST BREAKFAST AT SEMICON WEST ON OCTOBER 14, 2026
12 Information Technology Stocks Moving In Wednesday's After-Market Session
- Press releasePRNewswire
CAMTEK ANNOUNCES RESULTS FOR THE SECOND QUARTER OF 2026
- Press releasePRNewswire
/C O R R E C T I O N -- Camtek Ltd./
- Press releasePRNewswire
CAMTEK TO REPORT SECOND QUARTER 2026 FINANCIAL RESULTS ON MONDAY, AUGUST 10, 2026
- Chandrima Sanyal
More Bark, More Beta: Corgi Debuts 31 Single-Stock ETFs Covering Nvidia, Tesla And More
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Similar companies
Companies in the same industry as Camtek
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.